Bleeding complications in BCR-ABL negative XXXX : prevalence, type, and risk factors in a single-center cohort.

@entity1 @entity1148 @entity548 @entity5 @entity117 @entity4016 @entity4015 @entity715 @entity4017 @entity2880
The BCR-ABL1-negative @entity5 ( @entity5 ) share an increased risk of @entity548 . Risk factors for @entity548 are less well defined than those for @entity715 . Because @entity1 with @entity4015 mutations have higher platelet counts compared to @entity4016 @entity4017 -mutated @entity1 , @entity548 rates may be increased in this group. Our aim was to retrospectively evaluate whether @entity2880 ( @entity2880 ), @entity1148 , mutational status, or treatment history are associated with @entity548 in a cohort of @entity5 @entity1 . Using an electronic database, @entity5 @entity1 seen between 2005 and 2013 were retrospectively identified using ICD-9 codes and billing records. A @entity548 event was defined as one that was identified in the medical record and graded based on the Common Terminology Criteria for Adverse Event (CTCAE) version 4.0. Among 351 @entity5 @entity1 , 15.6 % experienced 64 @entity548 event types. There was no association of @entity548 with mutational status, gender, @entity5 subtype, @entity117 use, prior @entity715 , or platelet count at presentation. There was an association between @entity548 and older age at diagnosis. aVWD was identified in six @entity1 . In this single-center retrospective study, @entity548 events were identified in 15 % of @entity1 , and associated with older age at diagnosis. aVWD was rarely tested for in this cohort.
